Injection/Infusion
SKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML
Summary
SKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML — Injection/Infusion containing risankizumab. Hong Kong Registration No. HK-68788. Certificate Holder: ABBVIE LIMITED. Date of Registration: 05 Aug, 2025.
Product NameSKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML
Registration No.HK-68788
Certificate HolderABBVIE LIMITED
Holder AddressUNIT 2405-08 24/F, AIA TOWER, 183 ELECTRIC ROAD, NORTH POINT, HONG KONG
Ingredientsrisankizumab
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration05 Aug, 2025
ATC codesL04AC18
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents
All ATC groupsL04
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。